Maekawa Koichi, Tsujino Takeshi, Saito Komei, Kim Jong Il, Ikeda Yoshihiro, Emoto Noriaki, Yokoyama Mitsuhiro
Department of Internal Medicine, Division of Cardiovascular and Respiratory Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Heart Vessels. 2006 Jul;21(4):205-12. doi: 10.1007/s00380-005-0889-6.
Impaired insulin-mediated vasodilation has been implicated in hypertension that is associated with the metabolic syndrome. The aim of this study was to determine whether an abnormality in membrane fatty acid composition was related to a weakening of insulin's inhibitory effect on agonist-stimulated intracellular free calcium elevation. Mild to moderate hypertensive patients (n = 27) and normotensive controls (n = 11) were studied. Hypertensive patients were divided into normoinsulinemic patients (n = 14) and hyperinsulinemic patients (n = 13) according to the area under the curve of plasma insulin concentrations during a 75-g oral glucose tolerance test. Nonstimulated and arginine-vasopressin (AVP) (1 micromol/l)-stimulated intraplatelet free calcium concentrations (pCa(2+)) were measured with or without insulin (100 microU/ml) preincubation. Platelet membrane fatty acid composition, intraerythrocyte sodium content, and the ouabain-sensitive sodium efflux rate constant (K (os)) of erythrocytes were also determined. Insulin preincubation reduced AVP-stimulated pCa(2+) elevation in both normotensive controls and hypertensive patients. The inhibitory effect of insulin on AVP-stimulated elevation of pCa(2+) (%Inhibition) was significantly (P < 0.05) blunted in hyperinsulinemic hypertensive patients (9.7% +/- 2.4%) as compared to normoinsulinemic hypertensive patients (17.4% +/- 2.7%) and normotensive controls (16.9% +/- 1.7%). In hypertensive patients, the %Inhibition was correlated negatively with saturated fatty acids (SFA) (r = -0.51, P < 0.05) and systolic blood pressure (r = -0.44, P < 0.05), and correlated positively with membrane polyunsaturated fatty acids (PUFA) (r = 0.53, P < 0.01) and K (os) (r = 0.53, P < 0.005). Multiple regression analysis showed that SFA, PUFA, and K (os) were the significant variables for %Inhibition. These findings indicate that an increase in SFA and a decrease in PUFA may cause insulin insensitivity in cellular calcium and sodium handling in hypertension with hyperinsulinemia.
胰岛素介导的血管舒张功能受损与代谢综合征相关的高血压有关。本研究的目的是确定膜脂肪酸组成异常是否与胰岛素对激动剂刺激的细胞内游离钙升高的抑制作用减弱有关。对轻度至中度高血压患者(n = 27)和血压正常的对照组(n = 11)进行了研究。根据75克口服葡萄糖耐量试验期间血浆胰岛素浓度曲线下面积,将高血压患者分为正常胰岛素血症患者(n = 14)和高胰岛素血症患者(n = 13)。在有无胰岛素(100微单位/毫升)预孵育的情况下,测量未刺激和精氨酸加压素(AVP)(1微摩尔/升)刺激后的血小板内游离钙浓度(pCa(2+))。还测定了血小板膜脂肪酸组成、红细胞内钠含量以及红细胞哇巴因敏感的钠外流速率常数(K (os))。胰岛素预孵育可降低血压正常的对照组和高血压患者中AVP刺激的pCa(2+)升高。与正常胰岛素血症高血压患者(17.4% +/- 2.7%)和血压正常的对照组(16.9% +/- 1.7%)相比,高胰岛素血症高血压患者中胰岛素对AVP刺激的pCa(2+)升高的抑制作用(%抑制率)显著降低(P < 0.05)(9.7% +/- 2.4%)。在高血压患者中,%抑制率与饱和脂肪酸(SFA)呈负相关(r = -0.51,P < 0.05),与收缩压呈负相关(r = -0.44,P < 0.05),与膜多不饱和脂肪酸(PUFA)呈正相关(r = 0.53,P < 0.01),与K (os)呈正相关(r = 0.53,P < 0.005)。多元回归分析表明,SFA、PUFA和K (os)是%抑制率的显著变量。这些发现表明,SFA增加和PUFA减少可能导致高胰岛素血症高血压患者在细胞钙和钠处理方面出现胰岛素不敏感。